Anemia and Patient Blood Management in Cardiac Surgery—Literature Review and Current Evidence

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 32, Issue 6, 2018, Pages 2726-2742

  Dhir, Achal ^a,b   Tempe, Deepak K ^c,d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c G B Pant Institute of Postgraduate Medical Education and Research   (India)

^d MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

anemia; bleeding; blood conservation; blood transfusion; cardiac surgery; patient blood management

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 7; DESMOPRESSIN;

ACUTE DISEASE; ACUTE NORMOVOLEMIC HEMODILUTION; ALTERNATIVE MEDICINE; ANEMIA; BLOOD CONSERVATION; BLOOD SALVAGE; BLOOD TRANSFUSION; CARDIAC PATIENT; CLINICAL OUTCOME; EXTRACTION RATIO; HEART DISEASE; HEART SURGERY; HEMODILUTION; HOSPITAL ACQUIRED ANEMIA; HUMAN; INTRAOPERATIVE PERIOD; LEUKAPHERESIS; OFF PUMP SURGERY; PATIENT CARE; POINT OF CARE TESTING; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT; TISSUE OXYGENATION; BLOOD; DISEASE MANAGEMENT; ERYTHROCYTE; PHYSIOLOGY; PROCEDURES; STANDARDS;

ANEMIA; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; DISEASE MANAGEMENT; ERYTHROCYTES; HUMANS;

EID: 85039906534     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2017.11.043     Document Type: Review

References (174)

1. Haas, J.D., Fairchild, M.W., Summary and conclusions of the International Conference on Iron Deficiency and Behavioral Development. Am J Cin Nutr 50 (1989), 703–705.
2. McLean, E., Cogswell, M., Egli, I., et al. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 12 (2009), 444–454.
3. Klein, A.A., Collier, T.J., Brar, M.S., et al. The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK - the first Association of Cardiothoracic Anaesthetists national audit. Anaesthesia 71 (2016), 627–635.
4. Hare, G.M.T., Freedman, J., Mazer, C.D., Risks of anemia and related management strategies: Can perioperative blood management improve patient safety?. Can J Anesth 60 (2013), 168–175.
5. Shander, A., Javidroozi, Ozawa, S., et al. What is really dangerous: Anaemia or transfusion?. BJA 107:S1 (2011), i41–i59.
6. Tsui, A.K., Marsden, P.A., Mazer, C.D., et al. Differential HIF and NOS responses to acute anemia: Defining organ-specific haemoglobin thresholds for tissue hypoxia. Am J Physiol Regul Integr Comp Physiol 307 (2014), R13–R25.
7. Tsui, A.K.Y., Dattani, N.D., Marsden, P.A., et al. Reassessing the risk of hemodilutional anemia: Some new pieces to an old puzzle. Can J Anesth 57 (2010), 779–791.
8. Hatcher, J.D., Chiu, L.K., Jennings, D.B., Anemia as a stimulus to aortic and carotid chemoreceptors in the cat. J Appl Physiol 44 (1978), 696–702.
9. Szlyk, P.C., King, C., Jennings, D.B., et al. The role of aortic chemoreceptors during acute anemia. Can J Physiol Pharmacol 62 (1984), 519–523.
10. Li, M., Bertout, J.A., Ratcliffe, S.J., et al. Acute anemia elicits cognitive dysfunction and evidence of cerebral cellular hypoxia in older rats with systemic hypertension. Anesthesiology 113 (2010), 845–858.
11. McLaren, A.T., Mazer, C.D., Zhang, H., et al. A potential role for inducible nitric oxide synthase in the cerebral response to acute hemodilution. Can J Anaesth 56 (2009), 502–509.
12. El Hasnaoui-Saadani, R., Pichon, A., Marchant, D., et al. Cerebral adaptations to chronic anemia in a model of erythropoietin deficient mice exposed to hypoxia. Am J Physiol Regul Integr Comp Physiol 296 (2009), R801–R811.
13. Deem, S., Hedges, R.G., McKinney, S., et al. Mechanisms of improvement in pulmonary gas exchange during isovolemic hemodilution. J Appl Physiol 87 (1999), 132–141.
14. Sproule, B.J., Mitchell, J.H., Miller, W.F., Cardiopulmonary physiological responses to heavy exercise in patients with anemia. J Clin Invest 39 (1960), 378–388.
15. Weiskopf, R.B., Viele, M.K., Feiner, J., et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. J Am Med Assoc 279 (1998), 217–221.
16. Madjdpour, C., Spahn, D.R., Allogeneic red blood cell transfusion: Physiology of oxygen transport. Best Pract Res Clin Anaesthesiol 21 (2007), 163–171.
17. Ragoonanan, T.E., Beattie, W.S., Mazer, C.D., et al. Metoprolol reduces cerebral tissue oxygen tension after acute hemodilution in rats. Anesthesiology 111 (2009), 988–1000.
18. van Bommel, J., Trouwborst, A., Schwarte, L., et al. Intestinal and cerebral oxygenation during severe isovolumic hemodilution and subsequent hyperoxic ventilation in a pig model. Anesthesiology 97 (2002), 660–670.
19. Wolff, C.B., Normal cardiac output, oxygen delivery and oxygen extraction. Adv Exp Med Biol 599 (2007), 169–182.
20. Halperin, M.L., Cheema-Dhadli, S., Lin, S.H., et al. Properties permitting the renal cortex to be the oxygen sensor for the release of erythropoietin: Clinical implications. Clin J Am Soc Nephrol 1 (2006), 1049–1053.
21. Johannes, T., Mik, E.G., Nohe, B., et al. Acute decrease in renal microvascular PO2 during acute normovolemic hemodilution. Am J Physiol Renal Physiol 292 (2007), F796–F803.
22. Bauer, C., Kurtz, A., Oxygen sensing in the kidney and its relation to erythropoietin production. Annu Rev Physiol 51 (1989), 845–856.
23. Searle, E., Pavord, A., Alfirevic, Z., Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 22 (2008), 1075–1088.
24. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105 (2006), 198–208.
25. Lipinski, M.J., Dewey, F.E., Biondi-Zoccai, G.G., et al. Hemoglobin levels predict exercise performance, ST-segment depression, and outcome in patients referred for routine exercise treadmill testing. Clin Cardiol 32 (2009), e22–e31.
26. Zoppini, G., Targher, G., Chonchol, M., et al. Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. Atherosclerosis 210 (2010), 575–580.
27. Musallam, K.M., Tamim, H.M., Richards, T., et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: A retrospective cohort study. Lancet 378 (2011), 1396–1407.
28. Baron, D.M., Hochrieser, H., Posch, M., et al. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 113 (2014), 416–423.
29. Gombotz, H., Rehak, P.H., Shander, A., et al. Blood use in elective surgery: The Austrian benchmark study. Transfusion 47 (2007), 1468–1480.
30. Viele, M.K., Weiskopf, R.B., What can we learn about the need for transfusion from patients who refuse blood? The experience from Jehovah's Witnesses. Transfusion 34 (1994), 396–401.
31. Carson, J.L., Noveck, H., Berlin, J.A., et al. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 42 (2002), 812–818.
32. Tobian, A.A., Ness, P.M., Noveck, H., et al. Time course and etiology of death in patients with severe anemia. Transfusion 49 (2009), 1395–1399.
33. Peterson, P.N., Magid, D.J., Lyons, E.E., et al. Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure. Am Heart J 159 (2010), 81–89.
34. Greenberg, G., Assali, A., Vaknin-Assa, H., et al. Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction. Am J Cardiol 105 (2010), 435–440.
35. Kurek, T., Lenarczyk, R., Kowalczyk, J., et al. Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 105 (2010), 611–618.
36. Carson, J.L., Duff, A., Poses, R.M., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348 (1996), 1055–1060.
37. Weiss, G., Goodnough, L.T., Anemia of chronic disease. N Engl J Med 352 (2005), 1011–1023.
38. Choosing Wisely. Available at: http://www.choosingwisely.org. Accessed July 23, 2016.
39. Hogan, M., Klein, A.A., Richards, T., The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery. Eur J Cardiothorac Surg 47 (2015), 218–226.
40. DeFoe, G.R., Ross, C.S., Olmstead, E.M., et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg 71 (2001), 769–776.
41. Habib, R.H., Zacharias, Schwann, et al. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: Should current practice be changed?. J Thorac Cardiovasc Surg 125 (2003), 1438–1450.
42. Karkouti, K., Djaiani, G., Borger, M.A., et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg 80 (2005), 1381–1387.
43. Karkouti, K., Beattie, W.S., Wijeysundera, D.N., et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg 129 (2005), 391–400.
44. Hogervorst, E., Rosseel, P., Van der Bom, J., et al. Tolerance of intraoperative hemoglobin decrease during cardiac surgery. Transfusion 54:10 Pt 2 (2014), 2696–2704.
45. Doak, G.J., Hall, R.I., Does hemoglobin concentration affect perioperative myocardial lactate flux in patients undergoing coronary artery bypass surgery?. Anesth Analg 80 (1995), 910–916.
46. Spahn, D.R., Smith, L.R., Veronee, C.D., et al. Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised blood flow. J Thorac Cardiovasc Surg 105 (1993), 694–704.
47. Mathru, M., Kleinman, B., Blakeman, B., et al. Cardiovascular adjustments and gas exchange during extreme hemodilution in humans. Crit Care Med 19 (1991), 700–704.
48. Fang, W.C., Helm, R.E., Krieger, K.H., et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 96:9 Suppl (1997), II-194–II-199.
49. Kirklin, J.W., Hypothermia, circulatory arrest and cardiopulmonary bypass. Kirklin, J.W., Barratt-Boyes, B.G., (eds.) Cardiac surgery, 1993, Churchill Livingstone, New York, 62–73.
50. Cooper, M.M., Elliot, M.J., Haemodilution. Jonas, R.A., Elliot, M.J., (eds.) Cardiopulmonary bypass in neonates, infants and young children, 1994, Butterworth-Heinemann, Oxford, UK, 82–99.
51. Duebener, L.F., Sakamoto, T., Hatsuoka, S., et al. Effects of hematocrit on cerebral microcirculation and tissue oxygenation during deep hypothermic bypass. Circulation 104:12 Suppl 1 (2001), I260–I264.
52. Vermeulen Windsant, I.C., de Wit, N.C.J., Sertorio, J.T.C., et al. Hemolysis during cardiac surgery is associated with increased intravascular nitric oxide consumption and perioperative kidney and intestinal tissue damage. Front Physiol, 5, 2014, 340.
53. Spahn, D.R., Zacharowski, K., Non-treatment of preoperative anaemia is substandard clinical practice. Br J Anaesth 115 (2015), 1–3.
54. Munoz, M., Gomez-Ramirez, S., Kozek-Langeneker, S., et al. ‘Fit to fly’: Overcoming barriers to preoperative haemoglobin optimization in surgical patients. Br J Anaesth 115 (2015), 15–24.
55. Zhang, H., Zhang, P., Yan, J., et al. Effects of erythropoiesis-stimulating agents on heart failure patients with anemia: A meta-analysis. Postepy Kardiol Interwencyjnej 12 (2016), 247–253.
56. Kansagara, D., Dyer, E., Englander, H., et al. Treatment of anemia in patients with heart disease: A systematic review. Ann Intern Med 159 (2013), 746–757.
57. Qaseem, A., Humphrey, L.L., Fitterman, N., et al. Treatment of anemia in patients with heart disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med 159 (2013), 770–779.
58. Hildebrandt, P.R., Bruun, N.E., Nielsen, O.W., et al. Effects of administration of iron isomaltoside 1000 in patients with chronic heart failure. A pilot study. Transfus Altern Transfus Med 11 (2010), 131–137.
59. Yoo, Y.C., Shim, J.K., Kim, J.C., et al. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 115 (2011), 929–937.
60. Khalafallah, A.A., Yan, C., Al-Badri, R., et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: A prospective, open-label, randomised controlled trial. Lancet Haematol 3 (2016), e415–e425.
61. Johansson, P.I., Rasmussen, A.S., Thomsen, L.L., Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: A randomized double blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang 109 (2015), 257–266.
62. Le Manach, Y., Syed, S., Erythrocyte transfusion: Remedy or poison?. Anesthesiology 117 (2012), 1153–1155.
63. Kulier, A., Levin, J., Moser, R., et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation, 116, 2007, 471.
64. Frank, S.M., Savage, W.J., Rothschild, J.A., et al. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 117 (2012), 99–106.
65. Frank, S.M., Resar, L.M.S., Rothschild, J.A., et al. A novel method of data analysis for utilization of red blood cell transfusion. Transfusion 53 (2013), 3052–3059.
66. Brown, C.H. IV, Savage, W.J., Masear, C.G., et al. Odds of transfusion for older adults compared to younger adults undergoing surgery. Anesth Analg 118 (2014), 1168–1178.
67. Takei, T., Amin, N.A., Schmid, G., et al. Progress in global blood safety for HIV. J Acquir Immune Defic Syndr 52:Suppl 2 (2009), s127–s131.
68. Sullivan, M.T., Cotten, R., Read, E.J., et al. Blood collection and transfusion in the United States in 2001. Transfusion 47 (2007), 385–394.
69. Bennett-Guerrero, E., Zhao, Y., O'Brien, S.M., et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 304 (2010), 1568–1575.
70. Snyder-Ramos, S.A., Mohnle, P., Weng, Y.S., et al. The ongoing variability in blood transfusion practices in cardiac surgery. Transfusion 48 (2008), 1284–1299.
71. Marik, P.E., Corwin, H.L., Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature. Crit Care Med 36 (2008), 2667–2674.
72. Goodnough, L.T., Marques, M.B., Zika virus and patient blood management. Anesth Analg 124 (2017), 282–289.
73. Madjdpour, C., Spahn, D.R., Allogeneic red blood cell transfusions: Efficacy, risks, alternatives and indications. Br J Anaesth 95 (2005), 33–42.
74. Cata, J., Wang, H., Gottumukkala, V., et al. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 110 (2013), 690–701.
75. Ferraris, V.A., Hochstetler, M., Martin, J.T., et al. Blood transfusion and adverse surgical outcomes: The good and the bad. Surgery 158 (2015), 608–617.
76. Surgenor, S.D., DeFoe, G.R., Fillinger, M.P., et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low output heart failure. Circulation 114:1 Suppl (2006), I43–I48.
77. Koch, C.G., Li, L., Duncan, A.I., et al. Morbidity and mortality risk associated with red blood cell and blood component transfusion in isolated coronary artery bypass grafting. Crit Care Med 34 (2006), 1608–1616.
78. Bahrainwala, Z.S., Grega, M.A., Hogue, C.W., et al. Intraoperative hemoglobin levels and transfusion independently predict stroke after cardiac operations. Ann Thorac Surg 91 (2011), 1113–1118.
79. Veenith, T., Sharples, L., Gerrard, C., et al. Survival and length of stay following blood transfusion in octogenarians following cardiac surgery. Anaesthesia 65 (2010), 331–336.
80. Vivacqua, A., Koch, C.G., Yousuf, A.M., et al. Morbidity of bleeding after cardiac surgery: Is it blood transfusion, reoperation for bleeding, or both?. Ann Thorac Surg 91 (2011), 1780–1790.
81. Aykut, G., Kilercik, M., Arıtürk, C., et al. Correction of dilutional anemia induces renal dysfunction in diabetic patients undergoing coronary artery bypass grafting: A consequence of microcirculatory alterations?. J Nephrol, 2017 Mar 22, https://doi.org/10.1007/s40620-017-0388-8 [E-pub ahead of print].
82. Loor, G., Rajeswaran, J., Li, L., et al. The least of 3 evils: Exposure to red blood cell transfusion, anemia, or both?. J Thorac Cardiovasc Surg 146 (2013), 1480–1487.
83. Shander, A., Fink, A., Javidroozi, et al. Appropriateness of allogeneic red blood cell transfusion: The international consensus conference on transfusion outcomes. Transfus Med Rev 25 (2011), 232–246.
84. Ferraris, V.A., Brown, J.R., Despotis, G.J., et al. 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg 91 (2011), 944–982.
85. Retter, A., Wyncoll, D., Pearse, R., et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol 160 (2013), 445–464.
86. Australian and New Zealand Society of Blood Transfusion Ltd, Royal College of Nursing. Guidelines for the administration of blood products, ed 2. Available at: https://www.anzsbt.org.au/data/documents/guidlines/ANZSBT_Guidelines_Administration_Blood_Products_2ndEd_Dec_2011_Hyperlinks.pdf. Accessed January 12, 2016.
87. Napolitano, L.M., Kurek, S., Luchette, F.A., et al. Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care. Crit Care Med 37 (2009), 3124–3157.
88. Hamm, C.W., Bassand, J.P., Agewall, S., et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32 (2011), 2999–3054.
89. Carson, J.L., Grossman, B.J., Kleinman, S., et al. Red blood cell transfusion: A clinical practice guideline from the AABB. Ann Intern Med, 157, 2012, 49.
90. Liumbruno, G.M., Bennardello, F., Lattanzio, A., et al. Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus 9 (2011), 189–217.
91. Meier, J., Müller, M.M., Lauscher, P., et al. Perioperative red blood cell transfusion: Harmful or beneficial to the patient?. Transfus Med Hemother 39 (2012), 98–103.
92. Tircoveanu, R., van der Linden, P., Hemodilution and anaemia in patients with cardiac disease: What is the safe limit?. Curr Opin Anaesthesiol 21 (2008), 66–70.
93. Madjdpour, C., Spahn, D.R., Weiskopf, R.B., Anemia and perioperative red blood cell transfusion: A matter of tolerance. Crit Care Med 34:5 Suppl (2006), s102–s108.
94. Pape, A., Stein, P., Horn, O., et al. Clinical evidence of blood transfusion effectiveness. Blood Transfus 7 (2009), 250–258.
95. Loor, G., Li, L., Sabik, J.F., et al. Nadir hematocrit during cardiopulmonary bypass: End organ dysfunction and mortality. J Thorac Cardiovasc Surg 144 (2012), 654–662.
96. Hare, G.M., Mu, A., Romaschin, A., et al. Plasma methemoglobin as a potential biomarker of anemic stress in humans. Can J Anesth 59 (2012), 348–356.
97. Holst, L.B., Petersen, M.W., Haase, N., et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion: Systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ, 350, 2015, h1354.
98. Carson, J.L., Carless, P.A., Hebert, P.C., Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev, 4, 2012 CD002042.
99. Hebert, P.C., Wells, G., Marshall, J., et al. Transfusion requirements in critical care: A pilot study-Canadian Critical Care Trials Group. JAMA 273 (1995), 1439–1444.
100. Hajjar, L.A., Vincent, J.-L., Galas, F.R.B.G., et al. Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 304 (2010), 1559–1567.
101. Mirski, M.A., Frank, S.M., Kor, D.J., et al. Restrictive and liberal red cell transfusion strategies in adult patients: Reconciling clinical data with best practice. Crit Care Med, 19, 2015, 202.
102. Ripolles-Melchor, J., Casans Frances, R., Espinosa, A., et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion in critically ill patients and in patients with acute coronary syndrome: A systematic review, meta-analysis and trial sequential analysis. Minerva Anestesiologica 82 (2016), 582–598.
103. Rygard, S.L., Holst, L.B., Wetterslev, J., et al. Long-term outcomes in patients with septic shock transfused at a lower versus higher haemoglobin threshold: The TRISS randomized multicenter clinical trial. Intensive Care Med 42 (2016), 1685–1694.
104. de Gast-Bakker, D.H., Wilde, R.B.P., Hazekamp, M.G., et al. Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: A randomized controlled trial. Intensive Care Med 39 (2013), 2011–2019.
105. Keir, A., Pal, S., Trivella, M., et al. Adverse effects of red blood cell transfusions in neonates: A systematic review and meta-analysis. Transfusion 56 (2016), 2773–2780.
106. Cholette, J.M., Swartz, M.F., Rubenstein, J., et al. Outcomes using a conservative versus liberal red blood cell transfusion strategy in infants requiring cardiac operation. Ann Thorac Surg 103 (2017), 206–214.
107. Shehata, N., Burns, L.A., Nathan, H., et al. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion 52 (2012), 91–99.
108. Patel, N.N., Avlonitis, V.S., Jones, H.E., et al. Indications for red blood cell transfusion in cardiac surgery: A systematic review and meta-analysis. Lancet Haematol 2 (2015), e543–e553.
109. Murphy, G.J., Pike, K., Rogers, C.A., et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 372 (2015), 997–1008.
110. Nakamura, R.E., Vincent, J.L., Fukushima, J.T., et al. A liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 150 (2015), 1314–1320.
111. Fominskiy, E., Putzu, A., Monaco, F., et al. Liberal transfusion strategy improves survival in perioperative but not in critically ill patients: A meta-analysis of randomised trials. Br J Anaesth 115 (2015), 511–519.
112. Docherty, A.B., O'Donnell, R., Brunskill, S., et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: Systematic review and meta-analysis. BMJ, 352, 2016, i1351.
113. Hovaguimian, F., Myles, P.S., Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: A context-specific systematic review and meta-analysis of randomized controlled trials. Anesthesiology 125 (2016), 46–61.
114. Simon, G.I., Craswell, A., Thom, O., et al. Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: A systematic review and meta-analysis. Lancet Haematol 4 (2017), e465–e474.
115. Villanueva, C., Colomo, A., Bosch, A., et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 368 (2013), 11–21.
116. Vermeulen Windsant, I.C., Hanssen, S.J., Buurman, W.A., et al. Cardiovascularsurgery and organ damage: Time to reconsider the role of hemolysis. J Thorac Cardiovasc Surg 142 (2011), 1–11.
117. Papp, J., Toth, A., Sandor, B., et al. The influence of on-pump and off-pump coronary artery bypass grafting on hemorheological parameters. Clin Hemorheol Microcirc 49 (2011), 331–346.
118. Astin, R., Puthucheary, Z., Anaemia secondary to critical illness: An unexplained phenomenon. Extrem Physiol Med, 3, 2014, 4.
119. Karkouti, K., Callum, J., Wijeysundera, D.N., et al. Point-of-care hemostatic testing in cardiac surgery: A stepped-wedge clustered randomized controlled trial. Circulation 134 (2016), 1152–1162.
120. Deppe, A.C., Weber, C., Zimmermann, J., et al. Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: A meta-analysis of 8332 patients. J Surg Res 203 (2016), 424–433.
121. Serraino, G.F., Murphy, G.J., Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: Updated systematic review and meta-analysis. Br J Anaesth 118 (2017), 823–833.
122. Koch, C.G., Li, L., Sessler, D.I., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358 (2008), 1229–1239.
123. Lelubre, C., Piagnerelli, Vincent, J.L., Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patents: Myth or reality?. Transfusion 49 (2009), 1384–1394.
124. Lacroix, J., Hebert, P.C., Fergusson, D.A., et al. Age of transfused blood in critically ill adults. N Engl J Med 372 (2015), 1410–1418.
125. Steiner, M.E., Ness, P.M., Assmann, S.F., et al. Effect of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 372 (2015), 1419–1429.
126. Heddle, N.M., Cook, R.J., Arnold, D.M., et al. Effect of short-term vs. long-term blood storage on mortality after transfusion. N Engl J Med 375 (2016), 1937–1945.
127. Chai-Adisaksopha, C., Alexander, P.E., Guyatt, G., et al. Mortality outcomes in patients transfused with fresher versus older red blood cells: A meta-analysis. Vox Sanguinis 112 (2017), 268–278.
128. D'Alessandro, A., Liumbruno, G., Grazzini, G., et al. Red blood cell storage: The story so far. Blood Transfus 8 (2010), 82–88.
129. Wozniak, M.J., Qureshi, S., Dott, W., et al. Randomized trial of red cell washing for the prevention of transfusion associated organ injury in cardiac surgery. Br J Anaesth 118 (2017), 689–698.
130. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force. Transfus Med 8 (1998), 59–71.
131. Heddle, N.M., Blajchman, M.A., Meyer, R.M., et al. A randomized controlled trial comparing the frequency of acute reaction to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 42 (2002), 556–566.
132. Kientz, D., Laforet, M., Isola, H., et al. Leucodepletion of platelet concentrates and plasma collected with haemonetics MCS + apheresis system. Experience of EFS-Alsace. Transfus Apheresis Sci 25 (2001), 55–59.
133. Paglino, J.C., Pomper, G.J., Fisch, G.S., et al. Reduction of febrile but not allergic reaction to RBCs and platelets after conversion to universal pre storage leukoreduction. Transfusion 44 (2004), 16–24.
134. Kwon, S., Lew, S., Chamberlain, R.S., Leukocyte filtration and postoperative infections. J Surg Res 205 (2016), 499–509.
135. Ranucci, M., Bank blood shortage, transfusion containment and viscoelastic point-of-care coagulation testing in cardiac surgery. Br J Anaesth 118 (2017), 814–815.
136. Johnson, J.L., Moore, E.E., Gonzalez, R.J., et al. Alteration of the post injury hyper inflammatory response by means of resuscitation with a red cell substitute. J Trauma 54 (2003), 133–139.
137. Chang, T.M.S., Hemoglobin-based red blood cell substitutes. Artif Organs 28 (2004), 789–794.
138. Kim, H.W., Greenburg, A.G., Artificial oxygen carriers as red blood cell substitutes: A selected review and current status. Artif Organs 28 (2004), 813–828.
139. Mackenzie, C.F., Bucci, C., Artificial oxygen carriers for trauma: Myth or reality. Hosp Med 65 (2004), 582–588.
140. Spahn, D.R., Waschke, K., Standl, T., et al. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood loss non-cardiac surgery: Results of a European phase 3 study. Anesthesiology 97 (2002), 1338–1349.
141. Gould, S.A., Moore, E.E., Hoyt, D.B., et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 195 (2002), 445–452.
142. Farrar, D., Grocott, M., Intravenous artificial oxygen carriers. Hosp Med 64 (2003), 352–356.
143. Spahn, D.R., Kocian, R., Artificial O2 carriers: Status in 2005. Curr Pharm Design 11 (2005), 4099–4114.
144. Hassan, N., Pierre, R.T., Marques, M.B., Society for the Advancement of Patient Blood Management and Anesthesia & Analgesia: A new collaboration and home for blood management research. Anesth Analg 123 (2016), 816–817.
145. Szczepiorkowski, Z.M., Dunbar, N.M., Transfusion guidelines: When to transfuse. Hematology Am Soc Hematol Educ Program 2013 (2013), 638–644.
146. Williamson, L.M., Devine, D.V., Challenges in the management of the blood supply. Lancet 381 (2013), 1866–1875.
147. Spahn, D.R., Goodnough, L.T., Alternatives to blood transfusion. Lancet 381 (2013), 1855–1865.
148. Gross, I., Seifert, B., Hofmann, A., et al. Patient blood management in cardiac surgery results in fewer transfusions and better outcome. Transfusion 55 (2015), 1075–1081.
149. Shander, A., Bracey AW, J.R., Goodnough, L.T., et al. Patient blood management as standard of care. Anesth Analg 123 (2016), 1051–1053.
150. British Committee for Standards in Haematology, Transfusion Task Force, Boulton, F.E., James, V., Guidelines for policies on alternatives to allogeneic blood transfusion. 1. Predeposit autologous blood donation and transfusion. Transfus Med 17 (2007), 354–365.
151. Bainbridge, D., Martin, J., Cheng, D., Off pump coronary artery bypass graft surgery versus conventional coronary artery bypass graft surgery: A systematic review of the literature. Semin Cardiothorac Vasc Anesth 9 (2005), 105–111.
152. Laks, H., O'Connor, N.E., Pilon, R.N., et al. Acute normovolemic hemodilution: Effects on hemodynamics, oxygen transport, and lung water in anesthetized man. Surg Forum 24 (1973), 201–202.
153. Monk, T.G., Acute normovolemic hemodilution. Anesthesiol Clin North Am 23 (2005), 271–281.
154. Kreimeier, U., Messmer, K., Perioperative hemodilution. Transfus Apher Sci 27 (2002), 59–72.
155. Zhou, X., Zhang, C., Wang, Y., et al. Preoperative acute normovolemic hemodilution for minimizing allogeneic blood transfusion: A meta-analysis. Anesth Analg 121 (2015), 1443–1455.
156. Barile, L., Fominskiy, E., Tomasso, N.D., et al. Acute normovolemic hemodilution reduces allogeneic red blood cell transfusion in cardiac surgery: A systematic review and meta-analysis of randomized trials. Anesth Analg 124 (2017), 743–752.
157. Shander, A., Rijhwani, T.S., Acute normovolemic hemodilution. Transfusion 44:12 Suppl (2004), 26S–34S.
158. Waters, J.H., Red blood cell recovery and reinfusion. Anesthesiol Clin N Am 23 (2005), 283–294.
159. American Association of Blood Banks. Intraoperative blood management. Waters, J.H., (eds.) Perioperative blood management: A physician's handbook, ed 1, 2006, Karger, Bethesda, MD, 45–76.
160. Tempe, D., Bajwa, R., Cooper, A., et al. Blood conservation in small adults undergoing valve surgery. J Cardiothorac Vasc Anesth 10 (1996), 502–506.
161. Tempe, D.K., Banerjee, A., Virmani, S., et al. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery. J Cardiothorac Vasc Anesth 15 (2001), 326–330.
162. Shen, S., Zhang, J., Wang, W., et al. Impact of intra-operative cell salvage on blood coagulation in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass: A prospective randomized and controlled trial. J Transl Med, 14, 2016, 228.
163. Wademan, B.H., Galvin, S.D., Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults. Interact Cardiovasc Thorac Surg 18 (2014), 360–370.
164. Bignami, E., Cattaneo, M., Crescenzi, G., et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anaesthesiol Scand 60 (2016), 892–900.
165. Gringeri, A., Mannucci, P.M., Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors. Haemophilia 11 (2005), 611–619.
166. Hay, C.R., Brown, S., Collins, P.W., et al. The diagnosis and management of factor VIII and IX inhibitors: A guideline from the United Kingdom Haemophilia Centre Doctors’ Organisation. Br J Haematol 133 (2006), 591–605.
167. Peyvandi, F., Palla, R., Menegatti, M., et al. Introduction. Rare bleeding disorders: General aspects of clinical features, diagnosis, and management. Semin Thromb Hemost 35 (2009), 349–355.
168. Liumbruno, G., Bennardello, F., Lattanzio, A., et al. Recommendations for the transfusion of plasma and platelets. Blood Transfus 7 (2009), 132–150.
169. Yank, V., Tuohy, V., Logan, A.C., et al. Systematic review: Benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Inter Med 154 (2011), 529–540.
170. Moskowitz, D.M., McCullough, J.N., Shander, A., et al. The impact of blood conservation on outcomes in cardiac surgery: Is it safe and effective?. Ann Thorac Surg 90 (2010), 451–458.
171. Freedman, J., The ONTraC Ontario program in blood conservation. Transfus Apher Sci 50 (2014), 32–36.
172. Jassar, A.S., Ford, P.A., Haber, H.L., et al. Cardiac surgery in Jehovah's Witness patients: Ten-year experience. Ann Thorac Surg 93 (2012), 19–25.
173. National Blood Authority, Australia. Patient blood management guidelines. Available at: https://www.blood.gov.au/pbm-guidelines. Accessed June 20, 2017.
174. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 122 (2015), 241–275.